Show simple item record

dc.contributor.authorKelly, HAen_US
dc.contributor.authorChikandiwa, Aen_US
dc.contributor.authorWarman, Ren_US
dc.contributor.authorSegondy, Men_US
dc.contributor.authorSawadogo, Ben_US
dc.contributor.authorVasiljevic, Nen_US
dc.contributor.authorDidelot, M-Nen_US
dc.contributor.authorMeda, Nen_US
dc.contributor.authorWeiss, HAen_US
dc.contributor.authorDelany-Moretlwe, Sen_US
dc.contributor.authorMayaud, Pen_US
dc.contributor.authorLorincz, Aen_US
dc.date.accessioned2018-07-17T08:57:24Z
dc.date.available2018-05-03en_US
dc.date.issued2018-09-24en_US
dc.date.submitted2018-06-05T14:24:30.796Z
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/42226
dc.description.abstractOBJECTIVES: To evaluate associations of DNA methylation of the human tumour suppressor gene EPB41L3 with high-grade cervical intraepithelial neoplasia (CIN2+) and HIV-related factors among women living with HIV-1 (WLHIV) in Burkina Faso and South Africa. DESIGN: Case-control study of WLHIV aged 25-50 with histology-determined CIN2+ (cases, N = 152) and ≤CIN1 (controls, N = 210). METHODS: EPB41L3 methylation was measured by pyrosequencing of bisulphite converted DNA from exfoliated cervical specimens at baseline and 16 months later. Median methylation levels were compared across CIN grades using the Mann-Whitney test and Cuzick test for trend. EPB41L3 methylation levels were dichotomized into 'high' and 'low' using the 66.7 percentile point of the distribution in the controls. Associations of EPB41L3 methylation with HIV-related factors were estimated by logistic regression. RESULTS: Among 94 WLHIV in Burkina Faso and 268 in South Africa, median methylation levels at baseline for EPB41L3 increased with increasing CIN grade in both countries (P-trend <0.001).'High' methylation was more frequent among women with a longer time since HIV diagnosis in Burkina Faso [>5 years vs. ≤5 years; adjusted odds ratio (aOR) = 4.15, 95% CI 1.09-15.83, adjusted for age, CD4 count, high-risk HPV and CIN status], with low CD4 count in both countries (CD4 ≤200 vs. ≥350 cells/μl: aOR = 7.14, 95% CI 1.44-35.37 in Burkina Faso; aOR = 2.55, 95% CI 1.07-6.07 in South Africa), and with prolonged ART use in South Africa (ART >2 years vs. ART-naïve: aOR = 2.40, 95% CI: 1.23-4.69). CONCLUSION: Methylation of EPB41L3 DNA is elevated among WLHIV with CIN2+ and independently associated with lower CD4 count and ART use.en_US
dc.description.sponsorshipEuropean Commission (EC) 7th Framework Programme under grant agreement No. HEALTH-2010-F2-265396, UK Medical Research Council (MRC) PHINDS scheme (PH01/14-39) and Cancer Research UK [Grant number C569/A10404] to QMUL.en_US
dc.format.extent2227 - 2236en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofAIDSen_US
dc.rightsThis is an Accepted Manuscript of an article published in AIDS. Final version published online at http://dx.doi.org/10.1097/QAD.0000000000001932
dc.titleAssociations of human gene EPB41L3 DNA methylation and cervical intraepithelial neoplasia in women living with HIV-1 in Africa.en_US
dc.typeArticle
dc.identifier.doi10.1097/QAD.0000000000001932en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/30005021en_US
pubs.issue15en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume32en_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record